Boston Scientific Pre-Tax Income increased by 66.0% to $1.16B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 44.3%, from $805.00M to $1.16B. Over 4 years (FY 2021 to FY 2025), Pre-Tax Income shows an upward trend with a 33.2% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
This provides a view of profitability that is not skewed by varying tax rates or one-time tax credits.
A company's profits before the deduction of corporate income tax. It combines operating performance with non-operating f...
Used to compare companies across different tax jurisdictions to see who generates more raw profit.
income_before_tax| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $149.00M | $483.00M | $119.00M | $156.00M | $345.00M | $245.00M | $395.00M | $444.00M | $426.00M | $610.00M | $505.00M | $608.00M | $420.00M | $669.00M | $585.00M | $805.00M | $941.00M | $939.00M | $700.00M | $1.16B |
| QoQ Change | — | +224.2% | -75.4% | +31.1% | +121.2% | -29.0% | +61.2% | +12.4% | -4.1% | +43.2% | -17.2% | +20.4% | -30.9% | +59.3% | -12.6% | +37.6% | +16.9% | -0.2% | -25.5% | +66.0% |
| YoY Change | — | — | — | — | +131.5% | -49.3% | +231.9% | +184.6% | +23.5% | +149.0% | +27.8% | +36.9% | -1.4% | +9.7% | +15.8% | +32.4% | +124.0% | +40.4% | +19.7% | +44.3% |